Getting Innovations to Patients During Shutdowns Act

Key Points

• This bill allows the Food and Drug Administration to continue reviewing new drugs and medical devices even if the government shuts down.
• Usually, a shutdown stops the FDA from accepting new applications because the agency cannot collect the necessary fees while the government is closed.
• The plan lets companies submit their applications during a shutdown and gives them seven days after the government reopens to pay the required fees.
• If a company fails to pay the fees within that one-week window, the FDA will reject the application and stop the approval process for that product.
• This change is intended to make sure that new medicines and medical tools reach patients without being delayed by political budget disputes.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.